- Home
- HOOK vs LVTX Comparison
HOOK vs LVTX Comparison
Compare HOOK & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- LVTX
- Stock Information
- Founded
- HOOK 2011
- LVTX 2016
- Country
- HOOK United States
- LVTX Netherlands
- Employees
- HOOK N/A
- LVTX N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- HOOK Health Care
- LVTX Health Care
- Exchange
- HOOK Nasdaq
- LVTX Nasdaq
- Market Cap
- HOOK 24.5M
- LVTX 27.9M
- IPO Year
- HOOK 2019
- LVTX 2021
- Fundamental
- Price
- HOOK $1.99
- LVTX $0.94
- Analyst Decision
- HOOK Buy
- LVTX Buy
- Analyst Count
- HOOK 4
- LVTX 3
- Target Price
- HOOK $10.67
- LVTX $3.33
- AVG Volume (30 Days)
- HOOK 266.1K
- LVTX 119.3K
- Earning Date
- HOOK 03-21-2025
- LVTX 12-10-2024
- Dividend Yield
- HOOK N/A
- LVTX N/A
- EPS Growth
- HOOK N/A
- LVTX N/A
- EPS
- HOOK N/A
- LVTX N/A
- Revenue
- HOOK $49,999,000.00
- LVTX $7,345,000.00
- Revenue This Year
- HOOK $148.80
- LVTX $16.68
- Revenue Next Year
- HOOK N/A
- LVTX N/A
- P/E Ratio
- HOOK N/A
- LVTX N/A
- Revenue Growth
- HOOK 143.30
- LVTX N/A
- 52 Week Low
- HOOK $1.72
- LVTX $0.88
- 52 Week High
- HOOK $10.50
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- HOOK 45.83
- LVTX 34.42
- Support Level
- HOOK $1.80
- LVTX $0.91
- Resistance Level
- HOOK $1.99
- LVTX $1.01
- Average True Range (ATR)
- HOOK 0.24
- LVTX 0.06
- MACD
- HOOK 0.05
- LVTX 0.02
- Stochastic Oscillator
- HOOK 25.35
- LVTX 15.05
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.